Tuesday, January 18, 2022

JOE BIDEN - FOLKS, I'M NOT DESTROYING THE AMERICAN MALE LIKE I'VE BEEN DOING TO EVERYTHING ELSE? LOOK AT MY CRACKHEAD LAWYER SON! - Opioids and the Unattached Male

 JOE BIDEN'S DOCTRINE   -  TAKE EVERY JOB FROM EVERY AMERICAN (LEGAL) AND GIVE IT TO A 'CHEAP' LABOR ILLEGAL. THEN SEND THE TAX BILLS FOR THE ILLEGALS' WELFARE AND 'FREE' MEDICAL BACK TO THE AMERICAN ROBBED OF A JOB.

Opioids and the Unattached Male

 By Patrick T. Brown | January 17, 2022 | 5:03pm EST

 
 

Featured is a dummy symbolizing the opioid epidemic. (Photo credit: BRENDAN SMIALOWSKI/AFP via Getty Images)
Featured is a dummy symbolizing the opioid epidemic. (Photo credit: BRENDAN SMIALOWSKI/AFP via Getty Images)

The United States now averages about 275 drug-related deaths per day, largely from synthetic opioids such as fentanyl. Many are aware by now that the spike in drug overdoses has hit white men without a college degree hardest (though black men are, unfortunately, gaining ground in this area). But one factor continues to be underdiscussed: it is disproportionately a crisis of single men.

While this trend has been noticeable over the past decade, the pandemic-afflicted year of 2020 seems to have thrown fuel on the fire. The latest CDC data shows that 35,419 single and divorced prime-age (25- to 54-year-old) men died of drug-related causes, a 35 percent increase from the year before. The never-married make up about one-third of the prime-age male population, but compose two-thirds of that demographic’s drug-related deaths. Similarly, the share of prime-age divorced men who succumbed to drug overdoses was nearly twice their share of the population at large.

alcohol and drug related deaths and suicides 2010-2020

From 2010 to 2019, the drug-related death rate among never-married prime-age white men increased some 125 percent: from 52 deaths per 100,000 to 117 (including 2020 would show an even steeper rise, but the pandemic affected Census data collection). If single and divorced prime-age white men had seen opioid deaths rise by only the same rate as those deaths rose among their married counterparts, the U.S. would have seen 38,800 fewer deaths from drug-related causes over the past decade just among this demographic group.

prime age mail drug related deaths per 100K 2010-2019

A marriage certificate is no prophylactic against the scourge of drug overdoses, of course. Marital status is correlated with income, race, and age; while death certificates don’t report income, we know that married decedents are more likely to be white, older, and better-educated. Controlling for those factors still shows single men to be at greater risk of dying from drug-related causes than married ones.

drug related deaths 2010-2020

(All charts courtesy of the author.)

Any discussion of opioid deaths, then, should focus on the unique perils of the unattached male. Some scholars have indeed pointed out the trend. University of Maryland sociologist Phillip Cohen has previously noted that from 2007 to 2017, overall mortality rose among unmarried whites, driven by the increase in drug and alcohol deaths. (For blacks and Hispanics, slower to be hit by the rise in synthetic opioid use, mortality largely remained flat.) The Joint Economic Committee’s Social Capital Project, where I worked for two years, also highlighted the disproportionate effects on the never-married and divorced in its analysis of 2015 death records.

But analysts are often reluctant to discuss the problem in these terms. For one, precisely identifying the instrumental value of marriage can be tricky. No randomized controlled trials capture marriage’s benefits, and selection problems exist—people who can attract a spouse are probably qualitatively different than people who can’t. The traits and characteristics of someone who marries — being dependable and oriented for the future — are probably associated with more education and resistance to illicit drug use. An opioid user who is already single is also more likely to stay single.

But while we may not be able to precisely measure marriage’s causal impact on any given individual, there is no shortage of research that suggest marriage can play a very real role in helping ourselves, our children, and our communities. And while many factors go into the choice to marry, these decisions don’t happen in a vacuum. Strong evidence exists that the status quo in public policy can prejudice an individual’s decision-making for or against marriage, at least on the margin.

A 2019 HHS report found that marriage penalties in tax and transfer programs had the biggest impact on “working class families with incomes between 100 and 250% of the [Federal Poverty Level].” Some working-class and middle-class parents tell focus groups that they would like to marry but choose not to — for fear of losing the in-kind benefits they receive. Our public policies too often prod people toward less stable forms of union through benefit cliffs and implicit marginal tax rates.

As policymakers consider how incentives render young men more vulnerable to opioids, they should not limit themselves to public-health interventions and law enforcement action to stop the flow of illicit drugs. They should also remove state barriers that nudge young adults away from marriage, reform our education system to help young men become productive, marriageable contributors to society, and work on shaping an economy in which more men can be productive without having a college degree.

If marriage by itself does not guarantee better outcomes, it has the potential to transform people’s lives as an institution aimed at permanence, selflessness, and stability. Any agenda to combat the scourge of drug overdoses must include moving beyond agnosticism toward marriage’s potential benefits and undoing the barriers that make it harder for many adults to get married — and to live longer and healthier lives.

Patrick T. Brown (@PTBwrites) is an Ethics and Public Policy Center fellow.


 AMERICA'S BIGGEST THREAT LIVES ON WALL STREET. WE NEED TO BURN THEM DOWN!

Gravitas Plus: How Big Pharma pushes dangerous drugs and reaps profits




Big Pharma - How much power do drug companies have? | DW Documentary




Big Pharma - How much power do drug companies have? | DW Documentary


Dying for Drugs (Pharmaceutical Investigation Documentary) | Real Stories




Multinational Corporations Claim Challenging Monopoly Power Hurts Small Business

ANGELA WEISS/AFP via Getty Images
ANGELA WEISS/AFP via Getty Images
4:23

Multinational corporations, including big banks and big businesses represented by the Chamber of Commerce, are lobbying against a plan by New York State legislators to take on concentrated corporate monopoly power by claiming it will hurt small businesses.

The legislation, known as S.B.933A, would amount to the “most significant legal challenge to big tech monopoly power in the country,” according to Matt Stoller, the Director of Research at the American Economic Liberties Project.

“Right now, to be considered subject to monopolization law, a firm has to have 70 to 90% of a market, plus it has to engage in egregious behavior that economists measure as inefficient,” Stoller wrote of the legislation last year:

This bill would blow up that entire framework. First, a firm would only have to have 40% of a market to be considered dominant. Plus, firms that are powerful enough to set wages across an industry, ahem Amazon, would also be considered dominant. It wouldn’t be illegal to be dominant, but under this legislative framework, dominant firms would no longer be allowed to engage in predatory conduct or block competitors from the market. [Emphasis added]

A group of multinational corporations and various Chamber of Commerce branches, represented by the Partnership for New York City organization, wrote a letter to New York legislators and Gov. Kathy Hochul (D) — using allegations that small businesses will be hurt to lobby opposition against the legislation.

“This legislation purports to curb the excesses of the largest companies, particularly ‘big tech,’ but would instead create a new level of risk, cost, and potential liability for all New York state businesses, large and small,” the heads of various corporations write:

If enacted, this law would make New York far less attractive for business investment and job creation, since it will put restrictions on New York firms that their competitors in other states and most countries would not be subject to. It would also discourage competitive business activities that benefit consumers with lower prices and innovative products. Ultimately, the result of this legislation will be lost jobs and reduced tax revenues. [Emphasis added]

The implications of these changes would be significant. New York would be an outlier in its antitrust enforcement posture not only in the U.S., but internationally. Moreover, the new rules will not improve the ability of state authorities to prosecute bad business conduct that hurts consumers. New York already has effective antitrust laws that are vigorously enforced by the Attorney General’s Office, often in close coordination with the federal antitrust enforcement agencies and sister agencies in other states. [Emphasis added]

The anti-monopoly legislation, though, is only likely to affect corporations with concentrated market power, many of whom signed onto the letter — including American Express, Condé Nast, Pfizer, McGraw-Hill Education, and Sullivan & Cromwell LLP.

American Economic Liberties Project details that “only a small proportion of firms will have any changes to their legal obligations, as most firms do not have market power” as a result of the legislation.

“Large corporations are using small businesses as a shield to protect their own anti-competitive behavior, but most small and medium firms simply do not have enough market power to fall under this bill’s purview,” the group notes.

As data has long revealed, a handful of corporations dominate vital markets in the American economy from retail to pharmaceuticals — often outsourcing the manufacturing and production of their products to foreign countries.

According to the Open Markets Institute, corporations like “Worldwide Nike controls almost two-fifths of the sports shoe business, a number that has grown since its two main rivals, Adidas and Reebok, merged in 2005” while “Amazon sells 74 percent of all e-books sold online, and it sells 64 percent of all print books sold online.”

John Binder is a reporter for Breitbart News. Email him at jbinder@breitbart.com. Follow him on Twitter here



No comments: